Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.48 CAD | -4.00% | -7.69% | -26.15% |
May. 08 | LifeSpeak Q1 Net Loss Widens, Revenue Falls | MT |
May. 08 | LifeSpeak Inc. Brief: Q1 2024 Revenue of $12.4 million, Net loss of $1.6 Million | MT |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- Analyst opinion has improved significantly over the past four months.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- Low profitability weakens the company.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Software
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-26.15% | 20.81M | - | ||
+18.08% | 338B | B- | ||
+27.06% | 227B | B+ | ||
+3.17% | 152B | B | ||
+15.06% | 57.85B | D+ | ||
+19.00% | 34.22B | C+ | ||
+9.96% | 30.08B | B+ | ||
+165.25% | 29.88B | D+ | ||
+28.96% | 21.78B | B- | ||
+39.27% | 14.13B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- LSPK Stock
- Ratings LifeSpeak Inc.